GLMD (Galmed Pharmaceuticals Ltd.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q2'26, EPS (earnings per share) is anticipated at (0.39) USD. Learn more details at .

Revenue & EPS values are provided in USD

Q2'25Q3'25Q4'25Q1'26Q2'26
Revenue Reported—————Revenue Estimate1.45 M1.37 M1.30 M——Revenue SurpriseEPS Reported(0.63)(0.33)(0.80)(0.38)EPS Estimate(0.83)(0.54)(0.51)(0.38)(0.39)EPS Surprise+24.10%+38.89%-56.86%+0.00%
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.